{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:21:37Z","timestamp":1792783297842,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82505325"],"award-info":[{"award-number":["82505325"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["82574891"],"award-info":[{"award-number":["82574891"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s12012-026-10208-6","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:45:55Z","timestamp":1792086355000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sodium Butyrate Attenuates Doxorubicin Sardiotoxicity Through GPR41\/GPR43\u2013Sox4\u2013PI3K\/Akt Signaling"],"prefix":"10.1007","volume":"26","author":[{"given":"Huan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianxu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiani","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"10208_CR1","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","volume":"131","author":"D Cardinale","year":"2015","unstructured":"Cardinale, D., Colombo, A., Bacchiani, G., Tedeschi, I., Meroni, C. A., Veglia, F., Civelli, M., Lamantia, G., Colombo, N., Curigliano, G., Fiorentini, C., & Cipolla, C. M. (2015). Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation, 131, 1981\u20131988.","journal-title":"Circulation"},{"key":"10208_CR2","doi-asserted-by":"crossref","unstructured":"Schirone, L., D\u2019Ambrosio, L., Forte, M., Genovese, R., Schiavon, S., Spinosa, G., Iacovone, G., Valenti, V., Frati, G., & Sciarretta, S. (2022). Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay. Cells 11.","DOI":"10.3390\/cells11132000"},{"key":"10208_CR3","doi-asserted-by":"crossref","unstructured":"Bhutani, V., Varzideh, F., Wilson, S., Kansakar, U., Jankauskas, S. S., & Santulli, G. (2025). Doxorubicin-Induced Cardiotoxicity: A Comprehensive Update. J Cardiovasc Dev Dis 12.","DOI":"10.3390\/jcdd12060207"},{"key":"10208_CR4","doi-asserted-by":"publisher","first-page":"111708","DOI":"10.1016\/j.biopha.2021.111708","volume":"139","author":"PS Rawat","year":"2021","unstructured":"Rawat, P. S., Jaiswal, A., Khurana, A., Bhatti, J. S., & Navik, U. (2021). Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management. Biomedicine & Pharmacotherapy, 139, 111708.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10208_CR5","doi-asserted-by":"crossref","unstructured":"Qing, G., Huang, C., Pei, J., & Peng, B. (2025). Alteration of cardiac energetics and mitochondrial function in doxorubicin\u2013induced cardiotoxicity: Molecular mechanism and prospective implications (Review). International Journal Of Molecular Medicine 56.","DOI":"10.3892\/ijmm.2025.5624"},{"key":"10208_CR6","doi-asserted-by":"publisher","first-page":"1272479","DOI":"10.3389\/fmicb.2023.1272479","volume":"14","author":"J Zhu","year":"2023","unstructured":"Zhu, J., Lyu, J., Zhao, R., Liu, G., & Wang, S. (2023). Gut macrobiotic and its metabolic pathways modulate cardiovascular disease. Frontiers In Microbiology, 14, 1272479.","journal-title":"Frontiers In Microbiology"},{"key":"10208_CR7","doi-asserted-by":"publisher","first-page":"e70024","DOI":"10.1002\/cph4.70024","volume":"15","author":"N Kondapalli","year":"2025","unstructured":"Kondapalli, N., Katari, V., Dalal, K. K., Paruchuri, S., & Thodeti, C. K. (2025). Microbiota in Gut-Heart Axis: Metabolites and Mechanisms in Cardiovascular Disease. Comprehensive Physiology, 15, e70024.","journal-title":"Compr Physiol"},{"key":"10208_CR8","doi-asserted-by":"publisher","first-page":"1608658","DOI":"10.3389\/fcvm.2025.1608658","volume":"12","author":"Q Xu","year":"2025","unstructured":"Xu, Q., Liu, X., Wang, Z., Li, X., Jiang, Q., & Xu, M. (2025). Recent advancements and comprehensive analyses of butyric acid in cardiovascular diseases. Front Cardiovasc Med, 12, 1608658.","journal-title":"Front Cardiovasc Med"},{"key":"10208_CR9","doi-asserted-by":"publisher","first-page":"837509","DOI":"10.3389\/fphar.2021.837509","volume":"12","author":"P Amiri","year":"2021","unstructured":"Amiri, P., Hosseini, S. A., Ghaffari, S., Tutunchi, H., Ghaffari, S., Mosharkesh, E., Asghari, S., & Roshanravan, N. (2021). Role of butyrate, a gut microbiota derived metabolite, in cardiovascular diseases: A comprehensive narrative review. Frontiers In Pharmacology, 12, 837509.","journal-title":"Frontiers In Pharmacology"},{"key":"10208_CR10","doi-asserted-by":"publisher","first-page":"e033744","DOI":"10.1161\/JAHA.123.033744","volume":"13","author":"JM Seefeldt","year":"2024","unstructured":"Seefeldt, J. M., Homilius, C., Hansen, J., Lassen, T. R., Jespersen, N. R., Jensen, R. V., Boedtkjer, E., B\u00f8tker, H. E., & Nielsen, R. (2024). Short-Chain Fatty Acid Butyrate Is an Inotropic Agent With Vasorelaxant and Cardioprotective Properties. J Am Heart Assoc, 13, e033744.","journal-title":"J Am Heart Assoc"},{"key":"10208_CR11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s13668-024-00564-6","volume":"13","author":"X Wang","year":"2024","unstructured":"Wang, X., Dong, Y., Huang, R., Wang, F., Xie, J., Liu, H., Wang, Y., Wang, Y., Luo, S., & Hu, D. (2024). The Role of Short-Chain Fatty Acids in Myocardial Ischemia-Reperfusion Injury. Curr Nutr Rep, 13, 701\u2013708.","journal-title":"Curr Nutr Rep"},{"key":"10208_CR12","doi-asserted-by":"crossref","unstructured":"Modrego, J., Ortega-Hern\u00e1ndez, A., Goirigolzarri, J., Restrepo-C\u00f3rdoba, M. A., B\u00e4uerl, C., Cort\u00e9s-Mac\u00edas, E., S\u00e1nchez-Gonz\u00e1lez, S., Esteban-Fern\u00e1ndez, A., P\u00e9rez-Villacast\u00edn, J., Collado, M. C., & G\u00f3mez-Garre, D. (2023). Gut microbiota and derived short-chain fatty acids are linked to evolution of heart failure patients. International Journal Of Molecular Sciences 24.","DOI":"10.3390\/ijms241813892"},{"key":"10208_CR13","doi-asserted-by":"publisher","first-page":"114754","DOI":"10.1016\/j.isci.2026.114754","volume":"29","author":"S Zeng","year":"2026","unstructured":"Zeng, S., Xie, Q., Zhang, R., Yang, T., Liu, D., Zhang, J., Ma, S., & Qiu, X. (2026). Butyrate ameliorates doxorubicin-induced heart failure by inhibiting cardiomyocyte ferroptosis through the gut-heart axis. iScience, 29, 114754.","journal-title":"iScience"},{"key":"10208_CR14","doi-asserted-by":"publisher","first-page":"107096","DOI":"10.1016\/j.vph.2022.107096","volume":"146","author":"H Zhong","year":"2022","unstructured":"Zhong, H., Yu, H., Chen, J., Mok, S. W. F., Tan, X., Zhao, B., He, S., Lan, L., Fu, X., Chen, G., & Zhu, D. (2022). The short-chain fatty acid butyrate accelerates vascular calcification via regulation of histone deacetylases and NF-\u03baB signaling. Vascular Pharmacology, 146, 107096.","journal-title":"Vascular Pharmacology"},{"key":"10208_CR15","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1007\/s10787-025-01718-w","volume":"33","author":"M Xiang","year":"2025","unstructured":"Xiang, M., Wu, S., Liu, M., Zhang, B., Xia, X., Tan, W., & Xiang, S. (2025). Iota-carrageenan oligosaccharide ameliorates DSS-induced colitis in mice by mediating gut microbiota dysbiosis and modulating SCFAs-PI3K-AKT pathway. Inflammopharmacology, 33, 3443\u20133460.","journal-title":"Inflammopharmacology"},{"key":"10208_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2025.12.002","volume":"593","author":"Y Li","year":"2026","unstructured":"Li, Y., Li, T., Zhang, Y., Wang, Y., Wu, G., & Tan, Y. (2026). Microbial metabolites in the gut-brain axis: their impact on depression pathophysiology and treatment. Neuroscience, 593, 1\u20137.","journal-title":"Neuroscience"},{"key":"10208_CR17","doi-asserted-by":"publisher","first-page":"961536","DOI":"10.3389\/fmicb.2022.961536","volume":"13","author":"X Cheng","year":"2022","unstructured":"Cheng, X., Zhou, T., He, Y., Xie, Y., Xu, Y., & Huang, W. (2022). The role and mechanism of butyrate in the prevention and treatment of diabetic kidney disease. Frontiers In Microbiology, 13, 961536.","journal-title":"Frontiers In Microbiology"},{"key":"10208_CR18","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.7150\/ijbs.27173","volume":"14","author":"X Huang","year":"2018","unstructured":"Huang, X., Liu, G., Guo, J., & Su, Z. (2018). The PI3K\/AKT pathway in obesity and type 2 diabetes. International Journal Of Biological Sciences, 14, 1483\u20131496.","journal-title":"International Journal Of Biological Sciences"},{"key":"10208_CR19","doi-asserted-by":"publisher","first-page":"114244","DOI":"10.1016\/j.biopha.2023.114244","volume":"159","author":"MS Savova","year":"2023","unstructured":"Savova, M. S., Mihaylova, L. V., Tews, D., Wabitsch, M., & Georgiev, M. I. (2023). Targeting PI3K\/AKT signaling pathway in obesity. Biomedicine & Pharmacotherapy, 159, 114244.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10208_CR20","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1007\/s11010-021-04219-w","volume":"476","author":"W Qin","year":"2021","unstructured":"Qin, W., Cao, L., & Massey, I. Y. (2021). Role of PI3K\/Akt signaling pathway in cardiac fibrosis. Molecular And Cellular Biochemistry, 476, 4045\u20134059.","journal-title":"Molecular And Cellular Biochemistry"},{"key":"10208_CR21","doi-asserted-by":"publisher","first-page":"6744","DOI":"10.1038\/s41467-022-34559-0","volume":"13","author":"Y Sun","year":"2022","unstructured":"Sun, Y., Hu, L., Tao, Z., Jarugumilli, G. K., Erb, H., Singh, A., Li, Q., Cotton, J. L., Greninger, P., Egan, R. K., Ip, T., Benes, Y., Che, C. H., Mao, J., J. and, & Wu, X. (2022). Pharmacological blockade of TEAD-YAP reveals its therapeutic limitation in cancer cells. Nature Communications, 13, 6744.","journal-title":"Nature Communications"},{"key":"10208_CR22","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41419-021-03576-0","volume":"12","author":"X Xu","year":"2021","unstructured":"Xu, X., Zong, K., Wang, X., Dou, D., Lv, P., Zhang, Z., & Li, H. (2021). miR-30d suppresses proliferation and invasiveness of pancreatic cancer by targeting the SOX4\/PI3K-AKT axis and predicts poor outcome. Cell Death And Disease, 12, 350.","journal-title":"Cell Death And Disease"},{"key":"10208_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41420-022-01294-w","volume":"9","author":"Y Wang","year":"2023","unstructured":"Wang, Y., Zan, Y., Huang, Y., Peng, X., Ma, S., Ren, J., Li, X., Wei, L., Wang, X., Yuan, Y., Tang, J., Zhan, Z., Wang, Z., & Ding, Y. (2023). NSUN2 alleviates doxorubicin-induced myocardial injury through Nrf2-mediated antioxidant stress. Cell Death Discov, 9, 43.","journal-title":"Cell Death Discov"},{"key":"10208_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.tem.2020.12.003","volume":"32","author":"L Zhang","year":"2021","unstructured":"Zhang, L., Liu, C., Jiang, Q., & Yin, Y. (2021). Butyrate in Energy Metabolism: There Is Still More to Learn. Trends In Endocrinology And Metabolism, 32, 159\u2013169.","journal-title":"Trends In Endocrinology And Metabolism"},{"key":"10208_CR25","doi-asserted-by":"publisher","first-page":"996809","DOI":"10.3389\/fcvm.2022.996809","volume":"9","author":"H Qian","year":"2022","unstructured":"Qian, H., Qian, Y., Liu, Y., Cao, J., Wang, Y., Yang, A., Zhao, W., Lu, Y., Liu, H., & Zhu, W. (2022). Identification of novel biomarkers involved in doxorubicin-induced acute and chronic cardiotoxicity, respectively, by integrated bioinformatics. Front Cardiovasc Med, 9, 996809.","journal-title":"Front Cardiovasc Med"},{"key":"10208_CR26","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.jaci.2024.11.019","volume":"155","author":"L Yang","year":"2025","unstructured":"Yang, L., Wang, P., Gao, T., Huang, X., Lin, Z., Sweren, E., Li, Y., Chen, L., Alphonse, M. P., Zhang, J., & Wang, G. (2025). Melatonin treatment increases skin microbiota-derived propionic acid to alleviate atopic dermatitis. The Journal Of Allergy And Clinical Immunology, 155, 880\u2013891e889.","journal-title":"The Journal Of Allergy And Clinical Immunology"},{"key":"10208_CR27","doi-asserted-by":"publisher","first-page":"116948","DOI":"10.1016\/j.intimp.2026.116948","volume":"184","author":"F Li","year":"2026","unstructured":"Li, F., Zhao, Q., Zhang, J., Shen, Z., & Wang, H. (2026). Andrographolide attenuates neuroinflammation and apoptosis after spinal cord injury via PI3K-Akt pathway activation. International Immunopharmacology, 184, 116948.","journal-title":"International Immunopharmacology"},{"key":"10208_CR28","doi-asserted-by":"publisher","first-page":"120751","DOI":"10.1016\/j.jep.2025.120751","volume":"357","author":"J Zhang","year":"2026","unstructured":"Zhang, J., Li, X., Sun, L., Liu, H., Jia, T., Shen, H., Kang, B., Yang, Y., Guo, X., Huang, R., Wang, J., Ye, C., & Ma, J. (2026). Huanglian-ejiao decoction ameliorates doxorubicin-induced cardiomyocyte apoptosis and autophagic flux dysregulation by up-regulating ubiquilin1. Journal Of Ethnopharmacology, 357, 120751.","journal-title":"Journal Of Ethnopharmacology"},{"key":"10208_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.freeradbiomed.2024.08.001","volume":"223","author":"W Jiang","year":"2024","unstructured":"Jiang, W., Yu, L., Mu, N., Zhang, Z., & Ma, H. (2024). MG53 inhibits ferroptosis by targeting the p53\/SLC7A11\/GPX4 pathway to alleviate doxorubicin-induced cardiotoxicity. Free Radical Biology And Medicine, 223, 224\u2013236.","journal-title":"Free Radical Biology And Medicine"},{"key":"10208_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00001813-200503000-00004","volume":"16","author":"C Massart","year":"2005","unstructured":"Massart, C., Poirier, C., Fergelot, P., Fardel, O., & Gibassier, J. (2005). Effect of sodium butyrate on doxorubicin resistance and expression of multidrug resistance genes in thyroid carcinoma cells. Anti-Cancer Drugs, 16, 255\u2013261.","journal-title":"Anti-Cancer Drugs"},{"key":"10208_CR31","doi-asserted-by":"crossref","unstructured":"Eladwy, R. A., Fares, M., Alsherbiny, M. A., Chang, D., Li, C. G., & Bhuyan, D. J. (2025). Postbiotics Combination Synergises the Antiproliferative Effects of Doxorubicin in Gastric Cancer Cells: A Cellular and Molecular Deep Dive. International Journal Of Molecular Sciences 27.","DOI":"10.20944\/preprints202512.0721.v1"},{"key":"10208_CR32","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00432-006-0116-6","volume":"132","author":"D Engel","year":"2006","unstructured":"Engel, D., Nudelman, A., Levovich, I., Gruss-Fischer, T., Entin-Meer, M., Phillips, D. R., Cutts, S. M., & Rephaeli, A. (2006). Mode of interaction between butyroyloxymethyl-diethyl phosphate (AN-7) and doxorubicin in MCF-7 and resistant MCF-7\/Dx cell lines. Journal Of Cancer Research And Clinical Oncology, 132, 673\u2013683.","journal-title":"Journal Of Cancer Research And Clinical Oncology"},{"key":"10208_CR33","first-page":"1569","volume":"26","author":"M Louis","year":"2005","unstructured":"Louis, M., Rosato, R. R., Battaglia, E., N\u00e9guesque, A., Lapotre, A., Grant, S., & Bagrel, D. (2005). Modulation of sensitivity to doxorubicin by the histone deacetylase inhibitor sodium butyrate in breast cancer cells. International Journal Of Oncology, 26, 1569\u20131574.","journal-title":"International Journal Of Oncology"},{"key":"10208_CR34","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/jcp.29918","volume":"236","author":"L Zhang","year":"2021","unstructured":"Zhang, L., Lv, L., Zheng, N., Li, R., Yang, R., Li, T., Li, Y., Liu, Y., Luo, H., Li, X., Zhou, Y., Shan, H., Bai, B., & Liang, H. (2021). Suppression of Sox4 protects against myocardial ischemic injury by reduction of cardiac apoptosis in mice. Journal Of Cellular Physiology, 236, 1094\u20131104.","journal-title":"Journal Of Cellular Physiology"},{"key":"10208_CR35","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1007\/s12012-025-10072-w","volume":"25","author":"L Yuan","year":"2025","unstructured":"Yuan, L., Zhao, Q., Yan, P., Lin, J., & Qiu, X. (2025). SOX4 promotes ferroptosis to aggravate myocardial ischemia\/reperfusion injury through elevating DAPK1 expression. Cardiovascular Toxicology, 25, 1938\u20131951.","journal-title":"Cardiovascular Toxicology"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10208-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10208-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10208-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:45:57Z","timestamp":1792086357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10208-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10208"],"URL":"https:\/\/doi.org\/10.1007\/s12012-026-10208-6","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"24 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Institutional Animal Care and Use Committee of Air Force Medical University (IACUC-20241290) and were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"131"}}